middle.news
Anteris Registers 9.1M Shares, Accelerates DurAVR Heart Valve Trial
9:19am on Thursday 27th of November, 2025 AEDT
•
Healthcare
Read Story
Anteris Registers 9.1M Shares, Accelerates DurAVR Heart Valve Trial
9:19am on Thursday 27th of November, 2025 AEDT
Key Points
SEC Form S-1 filed to register 9.1 million shares for resale
Shares include private placement stock and warrants exercisable in 2026
DurAVR Transcatheter Heart Valve System progressing in global PARADIGM Trial
Proceeds from warrant exercises to support clinical development and R&D
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Anteris Technologies Global (ASX:AVR)
OPEN ARTICLE